HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A novel chordoma xenograft allows in vivo drug testing and reveals the importance of NF-κB signaling in chordoma biology.

Abstract
Chordoma is a rare primary bone malignancy that arises in the skull base, spine and sacrum and originates from remnants of the notochord. These tumors are typically resistant to conventional chemotherapy, and to date there are no FDA-approved agents to treat chordoma. The lack of in vivo models of chordoma has impeded the development of new therapies for this tumor. Primary tumor from a sacral chordoma was xenografted into NOD/SCID/IL-2R γ-null mice. The xenograft is serially transplantable and was characterized by both gene expression analysis and whole genome SNP genotyping. The NIH Chemical Genomics Center performed high-throughput screening of 2,816 compounds using two established chordoma cell lines, U-CH1 and U-CH2B. The screen yielded several compounds that showed activity and two, sunitinib and bortezomib, were tested in the xenograft. Both agents slowed the growth of the xenograft tumor. Sensitivity to an inhibitor of IκB, as well as inhibition of an NF-κB gene expression signature demonstrated the importance of NF-κB signaling for chordoma growth. This serially transplantable chordoma xenograft is thus a practical model to study chordomas and perform in vivo preclinical drug testing.
AuthorsMatteo M Trucco, Ola Awad, Breelyn A Wilky, Seth D Goldstein, Ruili Huang, Robert L Walker, Preeti Shah, Varalakshmi Katuri, Naheed Gul, Yuelin J Zhu, Edward F McCarthy, Ido Paz-Priel, Paul S Meltzer, Christopher P Austin, Menghang Xia, David M Loeb
JournalPloS one (PLoS One) Vol. 8 Issue 11 Pg. e79950 ( 2013) ISSN: 1932-6203 [Electronic] United States
PMID24223206 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • NF-kappa B
Topics
  • Animals
  • Antineoplastic Agents (therapeutic use)
  • Cell Line, Tumor
  • Chordoma (drug therapy, genetics, metabolism)
  • Drug Screening Assays, Antitumor (methods)
  • Gene Expression Profiling
  • Genotype
  • Humans
  • Immunohistochemistry
  • Mice
  • NF-kappa B (metabolism)
  • Polymerase Chain Reaction
  • Polymorphism, Single Nucleotide (genetics)
  • Transplantation, Heterologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: